IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I11A233

Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis

Fábio S. de Brito Jr1*, MD, PhD; Adriano M. Caixeta1, MD, PhD; Marcelo L. Vieira1, MD, PhD; Cesar Nomura1, MD, PhD; Geraldo L. Figueiredo2, MD; Marco Perin1, MD, PhD; J. Antonio Marin-Neto2, MD, PhD

A 70-year-old male underwent transfemoral transcatheter aortic valve implantation using a 26 mm SAPIEN XT valve (Edwards Lifesciences, Irvine, CA, USA). He received aspirin (100 mg/day) indefinitely and clopidogrel (75 mg/day) for one month. At six-month follow-up, the patient presented with recurrent symptoms of heart failure and angina. The echocardiogram depicted a severe transcatheter prosthesis stenosis, with a mean gradient of 48 mmHg. Multidetector computed tomography (MDCT) showed thickened leaflets along with low-density images, suggestive of thrombus (Figure1A, Figure1B, Moving image 1, Moving image 2). Two-dimensional (2D) transoesophageal echocardiography (TEE) also revealed echogenic images suggestive of thrombus surrounding the leaflets, which were more evident by 3D TEE (Online Figure 1A, Online Figure 1B, Moving image 3). Oral anticoagulation with coumadin was initiated and dual antiplatelet therapy was restarted. Three months later, repeat MDCT (Figure 1C, Figure 1D, Moving image 4, Moving image 5) and 2D and 3D TEE (Online Figure 1C, Online Figure 1D, Moving image 6) showed normal appearance of the prosthesis, with thin leaflets and a mean gradient of 6 mmHg. Lifelong anticoagulation was recommended.

Figure 1. Axial (A) and coronal (B) MDCT planes showing thickened leaflets with low-density images suggestive of thrombus (arrows). At follow-up, normal appearance of the prosthesis, with thin leaflets (C & D).

Conflict of interest statement

F. S. de Brito Jr and M. Perin receive honoraria for speeches and proctoring from Medtronic and Edwards Lifesciences. The other authors have no conflicts of interest to declare.

Online data supplement

Online Figure 1. Baseline 2D TEE (longitudinal and transversal planes) showing echogenic images suggestive of thrombus (arrows) inside the prosthesis (A). The thrombus image (arrow) became more evident by 3D TEE (B). Follow-up 2D (C) and 3D (D) TEE demonstrating disappearance of thrombus inside the prosthesis.

Moving image 1. Axial MDCT plane showing thickened leaflets with low-density images suggestive of thrombus.

Moving image 2. Coronal MDCT plane showing thickened leaflets with low-density images suggestive of thrombus.

Moving image 3. Baseline 2D TEE (longitudinal and transversal planes) showing echogenic images suggestive of thrombus inside the prosthesis.

Moving image 4. Axial MDCT plane showing normal appearance of the prosthesis at follow-up, with thin leaflets and absence of low-density images.

Moving image 5. Coronal MDCT plane showing normal appearance of the prosthesis at follow-up, with thin leaflets and absence of low-density images.

Moving image 6. Follow-up 2D TEE (longitudinal and transversal planes) demonstrating disappearance of thrombus inside the prosthesis.

Online Figure 1. Baseline 2D TEE (longitudinal and transversal planes) showing echogenic images suggestive of thrombus (arrows) inside the prosthesis (A). The thrombus image (arrow) became more evident by 3D TEE (B). Follow-up 2D (C) and 3D (D) TEE demonstrating disappearance of thrombus inside the prosthesis.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1.

Moving image 2.

Moving image 3.

Moving image 4.

Moving image 5.

Moving image 6.

Volume 10 Number 11
Mar 20, 2015
Volume 10 Number 11
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10I2A44 Jun 20, 2014
Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation
Leetmaa T et al
free

10.4244/EIJV7I1A28 May 17, 2011
Valve thrombosis after transcatheter heart valve implantation
Tay E et al
free

10.4244/EIJV15I7A102 Sep 20, 2019
Antithrombotic therapy after TAVI: where are we going?
Wilkins B et al
free

10.4244/EIJV11SWA28 Sep 17, 2015
Antithrombotic therapy in TAVI patients: changing concepts
Gargiulo G et al
free

10.4244/EIJV9SSA9 Sep 15, 2013
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
Collet J and Montalescot G
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA7 Sep 18, 2016
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing?
Chakravarty T et al
free

AORTIC VALVE INTERVENTIONS

10.4244/EIJV12SYA8 Sep 18, 2016
Late degeneration of transcatheter aortic valves: pathogenesis and management
Barbanti M and Tamburino C
free

Viewpoint

10.4244/EIJ-D-24-00205 Jul 15, 2024
Subclinical leaflet thrombosis: should we be concerned?
Dangas G and Bay B
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved